Ethical Limits On Enhancing Enzymatic Activity.

Ethical Limits on Enhancing Enzymatic Activity

1. Introduction

Enzymatic activity refers to the ability of enzymes to accelerate biochemical reactions within living cells. Enhancing enzymatic activity means increasing or modifying enzyme function through medicines, genetic techniques, metabolic interventions, or biological engineering.

Such enhancement may help treat enzyme deficiencies, improve metabolic functions, and support disease management. However, excessive or uncontrolled enzyme activity may disrupt normal biochemical balance and cause cellular damage.

The central ethical principle is that enzymatic enhancement must be safe, scientifically justified, and directed toward legitimate human benefit.

3. Case Laws

These cases concern enzyme-related treatment, genetic intervention, and medical research ethics. They provide relevant legal principles, although no major judgment directly addresses enhancement of enzymatic activity for non-therapeutic purposes.

1. Ward v. Schaefer (2024)

The case concerned experimental enzyme therapy for a patient with a genetic deficiency affecting an essential blood enzyme. The patient's estate alleged fraudulent inducement and failure to obtain informed consent. The First Circuit affirmed the judgment in favour of the defendant.

Justia Law

 

Principle: Experimental enzyme treatment raises questions of informed consent, research transparency, and responsibility for clinical risks.

Relevance: Enzymatic enhancement must be supported by adequate disclosure and responsible clinical research.

2. Jesse Gelsinger Case (1999)

Jesse Gelsinger died during a gene therapy clinical trial for ornithine transcarbamylase deficiency, a disorder involving an enzyme essential to ammonia metabolism. Investigations raised concerns about risk disclosure, participant selection, and conflicts of interest.

NYU Langone Health+1

 

Principle: Experimental biological interventions require rigorous safety review, honest disclosure, and independent oversight.

Relevance: Techniques intended to alter enzyme production or activity must not proceed without careful evaluation of risks and transparent consent.

3. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court of India emphasized that medical treatment requires valid, voluntary, and informed consent.

Principle: Consent must be based on adequate information about the procedure, its risks, and its alternatives.

Relevance: Patients undergoing enzymatic enhancement must understand the intended biological changes and possible complications.

4. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1

The Supreme Court of India recognized privacy as a fundamental right.

Principle: Personal autonomy, dignity, and privacy are protected under Article 21.

Relevance: Enzyme profiling and related biological data must be collected and used with proper privacy safeguards.

4. Indian Legal Framework

Article 21: Protects life, dignity, and personal liberty.

ICMR Ethical Guidelines, 2017: Establish ethical standards for biomedical research involving human participants.

New Drugs and Clinical Trials Rules, 2019: Regulate relevant investigational treatments and clinical research.

National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019: Provide safeguards for gene therapy research involving changes in biological function.

5. Conclusion

Enhancing enzymatic activity may help treat enzyme deficiencies and improve certain cellular functions. However, it must not cause uncontrolled biochemical reactions, unnecessary health risks, or unfair biological advantages.

The fundamental ethical limit is that enzymatic enhancement must serve legitimate medical benefit, supported by scientific evidence, informed consent, safety monitoring, and respect for human dignity.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT